Avoro Capital Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.3M | Sell |
|
|||||
|
2025
Q1 | $65.3M | Sell |
|
|||||
|
2024
Q4 | $89.2M | Hold |
|
|||||
|
2024
Q3 | $90.2M | Sell |
|
|||||
|
2024
Q2 | $77.7M | Sell |
|
|||||
|
2024
Q1 | $66.3M | Hold |
|
|||||
|
2023
Q4 | $78.2M | Buy |
|
|||||
|
2023
Q3 | $81.8M | Sell |
|
|||||
|
2023
Q2 | $84.9M | Buy |
|
|||||
|
2023
Q1 | $86.9M | Buy |
|
|||||
|
2022
Q4 | $104M | Hold |
|
|||||
|
2022
Q3 | $114M | Buy |
|
|||||
|
2022
Q2 | $68.8M | Buy |
|
|||||
|
2022
Q1 | $30.5M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.67M | Sell |
|
|||||
|
2017
Q3 | $9.32M | Sell |
|
|||||
|
2017
Q2 | $10.9M | Buy |
|
|||||
|
2017
Q1 | $13.5M | Sell |
|
|||||
|
2016
Q4 | $10.3M | Buy |
|
|||||
|
2016
Q3 | $6.08M | Buy |
|